| Cover | Oct. 11, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Document Period End Date | Oct. 11, 2024 |
| Entity Registrant Name | NURIX THERAPEUTICS, INC. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-39398 |
| Entity Tax Identification Number | 27-0838048 |
| Entity Address, Address Line One | 1700 Owens Street |
| Entity Address, Address Line Two | Suite 205 |
| Entity Address, City or Town | San Francisco |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94158 |
| City Area Code | 415 |
| Local Phone Number | 660-5320 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.001 par value per share |
| Trading Symbol | NRIX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
| Entity Central Index Key | 0001549595 |
| Document Fiscal Year Focus | 2024 |
| Document Fiscal Period Focus | FY |
| Amendment Flag | false |
